Purchase Order 140D0426P0149
Award Date 6/2/26
Potential Completion Date 7/4/27
Potential Value $33K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $17,749.98 on April 7, 2020, to provide a maintenance agreement. Performance is located in Marlborough, Massachusetts. The order is firm fixed price with an ultimate completion date of October 7, 2020. No small business set-aside was applied.</p>
- The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $15,300.00 on April 15, 2020, with ultimate completion by April 30, 2021. The order is firm fixed-price with no set-aside used. Work is performed in Bethesda, Maryland. Akoya, a small disadvantaged business and biotechnology company specializing in spatial phenotyping and tissue imaging solutions, supplies specialized imaging systems, reagents, and diagnostic technologies to support federal healthcare and...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Akoya Biosciences, Inc. (doing business as Phenoptics), a for-profit small disadvantaged business. The $16,560 contract is for a maintenance agreement on an Akoya Mantra quantitative imaging system (serial number MN1548N0024) located at the NCI campus in Bethesda, Maryland. The award does not utilize a set-aside and has an ultimate...
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $14,844.00 on March 27, 2019, with an ultimate completion date of April 30, 2020. Performance occurs in Menlo Park, California. The order is for a service agreement priced on a firm fixed-price basis. Akoya is a small disadvantaged business and manufacturer of advanced tissue imaging and spatial phenotyping solutions.</p>
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Akoya Biosciences, Inc. (doing business as Phenoptics), a for-profit manufacturer of medical imaging equipment and reagents. The contract, valued at $195,720, is for preventive maintenance services on one Akoya PhenoImager HT instrument over a 5-year period from July 2024 to June 2029. This award is not a set-aside...
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $13,400.00 on January 25, 2018, with completion targeted for February 25, 2018. The order is firm fixed price with no set-aside. Akoya is a small disadvantaged business specializing in spatial phenotyping and advanced tissue imaging solutions. Place of performance is Bethesda, Maryland. The specific scope of this order is not detailed in the source material.</p>
- This is a firm fixed-price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business manufacturer of goods, for a service contract to provide a PhenoCycler instrument. The total ceiling value of the contract is $10,020.00, and the ultimate completion date is July 30, 2025. The award is not associated with a set-aside program. Akoya Biosciences is a biotechnology company that specializes in...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to Akoya Biosciences, Inc., a self-certified small disadvantaged business. The contract has a potential value of $16,560.00 and a period of performance through April 30, 2025. Akoya, operating under the trade name Phenoptics, will provide goods and services to support medical imaging, diagnostic testing, and pathology operations. This includes the delivery of OPAL reagent packs,...
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $14,150.00 on January 17, 2019, with a completion date of February 18, 2019. No set-aside was used. Work is performed in San Francisco, California. Akoya is a small disadvantaged business specializing in spatial phenotyping and advanced tissue imaging solutions. The order is firm fixed-price.</p>
- The National Cancer Institute awarded a purchase order to Bruker Spatial Biology, Inc. for $115,072.04 on June 1, 2026, for maintenance and service of the Bruker GeoMx and CosMx systems through May 31, 2027. Work is performed in Bethesda, Maryland. The order covers preventative maintenance, emergency on-site service support, replacement parts, software updates, and unlimited technical telephone support during business hours for two government-owned laboratory instruments critical to cancer...